A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Mayo Clinic in Rochester, Rochester, Minnesota